Valneva SE (WBO:VLA) Short Percentage of Float


WBO:VLA Valneva SE WBO:VLA
58 GF Score
Price €2.24
GF Value €2.49
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WBO:VLA vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Valneva SE's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valneva SE Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Valneva SE's Short Percentage of Float falls into.


WBO:VLA
58GF Score
Valneva SE WBO:VLA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valneva SE (WBO:VLA) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.24 is trading 9.9% below its estimated GF Value™ of €2.49. GuruFocus considers Valneva SE to be Modestly Undervalued.

Key valuation signals for WBO:VLA:

  • Short Percentage of Float:
  • GF Value™: €2.49 vs. price of €2.24 (9.9% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the WBO:VLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
58GF Score

Get the complete analysis for WBO:VLA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.24
Price
€2.49
GF Value